Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Recurrent and Metastatic Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Paclitaxel|DRUG: AMG 706
Sponsor: Amgen